![](/images/general/no_picture/200_user.png)
Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17163174
[patent_doc_number] => 11149263
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Method for purifying and quantifying thrombin and its degradation polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/712207
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 19926
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712207 | Method for purifying and quantifying thrombin and its degradation polypeptides | Dec 11, 2019 | Issued |
Array
(
[id] => 17665307
[patent_doc_number] => 11358988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/711105
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 124117
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/711105 | Immunomodulators | Dec 10, 2019 | Issued |
Array
(
[id] => 17383947
[patent_doc_number] => 20220031799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF SENGERS SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/299681
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299681 | Methods and compositions for the treatment of Sengers syndrome | Dec 4, 2019 | Issued |
Array
(
[id] => 15895337
[patent_doc_number] => 20200147187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEONATAL BILIARY ATRESIA
[patent_app_type] => utility
[patent_app_number] => 16/703939
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703939 | Compositions and methods for treating neonatal biliary atresia | Dec 4, 2019 | Issued |
Array
(
[id] => 17428369
[patent_doc_number] => 20220056077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/420110
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420110 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | Dec 3, 2019 | Pending |
Array
(
[id] => 17266318
[patent_doc_number] => 11191722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Treatment of diabetes mellitus by long-acting formulations of insulins
[patent_app_type] => utility
[patent_app_number] => 16/700541
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 40189
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700541
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700541 | Treatment of diabetes mellitus by long-acting formulations of insulins | Dec 1, 2019 | Issued |
Array
(
[id] => 17625809
[patent_doc_number] => 20220160824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/298415
[patent_app_country] => US
[patent_app_date] => 2019-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298415 | COMPOUNDS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE | Nov 27, 2019 | Pending |
Array
(
[id] => 17292189
[patent_doc_number] => 20210388028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/295370
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295370 | GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF | Nov 19, 2019 | Abandoned |
Array
(
[id] => 17342172
[patent_doc_number] => 20220008503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => MATERIALS AND METHODS FOR THE PREVENTION OF RHEUMATOID ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/294091
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294091 | MATERIALS AND METHODS FOR THE PREVENTION OF RHEUMATOID ARTHRITIS | Nov 14, 2019 | Pending |
Array
(
[id] => 15990521
[patent_doc_number] => 20200171131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => FIBROIN-DERIVED PROTEIN COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/680186
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16680186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/680186 | Fibroin-derived protein composition | Nov 10, 2019 | Issued |
Array
(
[id] => 17775020
[patent_doc_number] => 20220241369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITIONS AND METHODS OF MODULATING INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/292639
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292639 | COMPOSITIONS AND METHODS OF MODULATING INFLAMMATION | Nov 10, 2019 | Pending |
Array
(
[id] => 17336012
[patent_doc_number] => 20220002343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/289408
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289408 | PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES | Nov 6, 2019 | Pending |
Array
(
[id] => 17290979
[patent_doc_number] => 20210386818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => COMPOSITIONS AND METHODS FOR THE PRODUCTION OF CYSTEINE
[patent_app_type] => utility
[patent_app_number] => 17/291812
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291812 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF CYSTEINE | Nov 5, 2019 | Pending |
Array
(
[id] => 17312889
[patent_doc_number] => 20210401937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITION AND METHOD FOR ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/289664
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289664 | COMPOSITION AND METHOD FOR ARTHRITIS | Oct 30, 2019 | Pending |
Array
(
[id] => 16406740
[patent_doc_number] => 10815283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-27
[patent_title] => Peptides for treatment of diabetes
[patent_app_type] => utility
[patent_app_number] => 16/666960
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 12
[patent_no_of_words] => 14412
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666960
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666960 | Peptides for treatment of diabetes | Oct 28, 2019 | Issued |
Array
(
[id] => 19181066
[patent_doc_number] => 11987648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Cyclohexapeptides as selective somatostatin SST5 receptor agonists
[patent_app_type] => utility
[patent_app_number] => 17/284399
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18334
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284399 | Cyclohexapeptides as selective somatostatin SST5 receptor agonists | Oct 13, 2019 | Issued |
Array
(
[id] => 17519301
[patent_doc_number] => 20220105149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => WS-635 USES THEREOF IN MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/429667
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429667 | WS-635 USES THEREOF IN MEDICINE | Oct 10, 2019 | Pending |
Array
(
[id] => 15451331
[patent_doc_number] => 20200038489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => Novel Use of Von Willebrand Factor
[patent_app_type] => utility
[patent_app_number] => 16/598373
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/598373 | Novel Use of Von Willebrand Factor | Oct 9, 2019 | Abandoned |
Array
(
[id] => 15454415
[patent_doc_number] => 20200040032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => PEPTIDE MACROCYCLES AND USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/596243
[patent_app_country] => US
[patent_app_date] => 2019-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16596243
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/596243 | Peptide macrocycles and use thereof in the treatment of bacterial infections | Oct 7, 2019 | Issued |
Array
(
[id] => 16428235
[patent_doc_number] => 10828296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Treatment of T-cell mediated diseases
[patent_app_type] => utility
[patent_app_number] => 16/591322
[patent_app_country] => US
[patent_app_date] => 2019-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9267
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16591322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/591322 | Treatment of T-cell mediated diseases | Oct 1, 2019 | Issued |